Summit Therapeutics
SMMT
#2227
Rank
NZ$15.28 B
Marketcap
NZ$19.11
Share price
-1.59%
Change (1 day)
-36.25%
Change (1 year)

Earnings for Summit Therapeutics (SMMT)

Earnings in 2026 (TTM): -NZ$1.46 Billion

According to Summit Therapeutics 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$1.97 Billion a decrease over its 2024 earnings that were of -NZ$0.41 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Summit Therapeutics from 2014 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$1.46 Billion-25.83%
2025 -NZ$1.97 Billion387.84%
2024 -NZ$0.41 Billion-64.01%
2023 -NZ$1.12 Billion680.54%
2022 -NZ$0.15 Billion-11.08%
2021 -NZ$0.17 Billion67.46%
2020 -NZ$96.3 Million29.71%
2019 -NZ$74.24 Million
2014 -NZ$58.11 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sarepta Therapeutics
SRPT
-NZ$0.24 Billion-84.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-NZ$4.12 Million-99.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
-NZ$0.28 Billion-81.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-NZ$1.15 Billion-24.71%๐Ÿ‡บ๐Ÿ‡ธ USA